The validation confirms the submission is complete, clearing the way for the EMA’s centralized review process to formally evaluate the therapy
Company may qualify for 180-day generic exclusivity as sole first applicant for Bayer’s Vitrakvi capsules in the U.S.
Approval expands treatment options for patients with unresectable or metastatic HER2-positive breast cancer
The acquisition reflects Johnson & Johnson’s push to strengthen its position in antibody engineering and next-generation oncology modalities
Consolidated entity plans to strengthen specialty pharmaceutical offerings, expand manufacturing capacity, and accelerate global market penetration across emerging regions
The move makes EBGLYSS the only therapy offering as few as six maintenance injections per year
Preclinical CRO strengthens leadership team with key executive appointments as it scales its human tissue-based drug discovery platform
Dengue, a mosquito-borne viral disease, is emerging as a growing public health threat across Africa
The campaign places renewed focus on a disease that remains incurable despite major scientific advances
Researchers say the results point to a potential shift in how obesity is treated—as a central disease driving multiple conditions, rather than a collection of separate problems
Subscribe To Our Newsletter & Stay Updated
